WaferGen Bio-Systems (WGBS) Misses Q2 EPS by 8c; Trims FY16 Revenue Outlook

WaferGen Bio-Systems (NASDAQ: WGBS) reported Q2 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.6 million.

At June 30, 2016, WaferGen had cash and cash equivalents of approximately $7.4 million.

GUIDANCE:

WaferGen Bio-Systems sees FY2016 revenue of $10-12 million, versus prior guidance of $12-13 million.

For earnings history and earnings-related data on WaferGen Bio-Systems (WGBS) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue